Keywords: Japan, New DPJ Administration, NHI pricing, R&D

Japan’s pharma industry awaits new DPJ Admin’s moves with some concerns

Article | 23 September 2009

As a result of the landslide victory of the Democratic Party of Japan (DPJ) in the recent national election, much ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in